Chronic Kidney Disease Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 09
SKU : PH790
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Chronic Kidney Disease Drugs Market ?
Global Chronic Kidney Disease Drugs Market was valued at US$ 10,923.29 million in 2021 and is estimated to reach US$ 19,427.41 million by 2031.
Who are the key players in Global Chronic Kidney Disease Drugs Market ?
Major players are AstraZeneca Plc, Sanofi S.A, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, AstraZeneca Plc, Kissei Pharmaceutical Co, AbbVie Inc, GlaxoSmithKline Plc, Amgen Inc, Akebia Therapeutics and Pfizer Inc.
Related Reports
medical-devices

End Stage Renal Disease Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 25
Starting from

$4350

medical-devices

Foley Catheter Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

medical-devices

Incontinence Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 30
Starting from

$4350

medical-devices

Kidney Stone Management Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 01
Starting from

$4350

medical-devices

Genital Dysfunction Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 02
Starting from

$4350

medical-devices

Renal Denervation Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 07
Starting from

$4350